Pneumococcal Conjugate Vaccine Pneumonia in Infants

Links shared publicly online about this topic

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

news-medical.net — “A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 19, 2010 at 5:43 am By:

NewsMedical News-Medical.Net Health News

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research: A pneumoco... http://bit.ly/ddBw0c

2 years ago...

Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification

news-medical.net — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 24, 2010 at 5:13 am By:

Lung_Breathing Lungs and Breathing OW Health

Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The World Health Organiz... http://bit.ly/c8uCg5

2 years ago...

Pfizer to supply pneumococcal conjugate vaccines for infants and children

news-medical.net — “Pfizer Inc. today announced it has signed a 10-year Provisional Supply Agreement to supply Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]), the company's 13-valent pneumococcal conjugate vaccine, for infants and young children in the world's poorest countries under the terms of the Advance Market Commitment (AMC) pilot project against pneumococcal disease.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 24, 2010 at 5:16 pm By:

Meningitis_News News-Medical.Net Health News

Meningitis News: Pfizer to supply pneumococcal conjugate vaccines for infants and children: Pfizer Inc. today anno... http://bit.ly/coSs8Q

2 years ago...

Pneumococcal conjugate vaccines effective at preventing child deaths, study suggests

feeds.sciencedaily.com — “A new study concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and X-ray defined pneumonia, were also effective against child deaths. According to the review, 80 percent of children were less likely to develop vaccine-type IPD, 58 percent all-serotype IPD, and 27 percent x-ray defined pneumonia than children who did not receive the vaccine. Eleven percent of child deaths were also prevented.View full resource at feeds.sciencedaily.com

  • View Related
  • Share

Most Recently Shared on November 18, 2009 at 1:12 am By:

sciencedaily sciencedaily Health News

Pneumococcal Conjugate Vaccines Effective At Preventing Child Deaths, Study Suggests: A new study concludes that pn... http://bit.ly/4AUOBj

3 years ago...

Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification

news-medical.net — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 24, 2010 at 5:19 am By:

Meningitis_News News-Medical.Net Health News

Meningitis News: Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The Wor... http://bit.ly/d3rUrU

2 years ago...

Pneumococcal vaccine has cut disease among Navajos | Reuters

reuters.com — “NEW YORK (Reuters Health) - The infant pneumococcal vaccine introduced 10 years ago has cut rates of pneumonia, meningitis and other infections among Navajos in the U.S. -- but their risks remain higherView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 22, 2010 at 6:03 pm By:

HITpol HealthIT Policy Health News and Health IT

Pneumococcal vaccine has cut disease among Navajos: NEW YORK (Reuters Health) - The infant pneumococcal vaccine in... http://bit.ly/9bs9yK

2 years ago...

Pneumococcal vaccine has cut disease among Navajos | Reuters

reuters.com — “NEW YORK (Reuters Health) - The infant pneumococcal vaccine introduced 10 years ago has cut rates of pneumonia, meningitis and other infections among Navajos in the U.S. -- but their risks remain higherView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 22, 2010 at 6:06 pm By:

Vaccine Reduces Pneumonia and Complications in Infants, Study Says - Drugs.com MedNews

drugs.com — “A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections,View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 20, 2010 at 12:22 pm By:

Lung_Breathing Lungs and Breathing OW Health

Vaccine Reduces Pneumonia and Complications in Infants, Study Says:     PHILADELPHIA, July 19 /PRNewswire-USNews... http://bit.ly/9gMHDY

2 years ago...

Medicine and Technology [part of HCPLive]: Prevention of Streptococcus pneumoniae Infections in Infants and Children

medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: Prevention of Streptococcus pneumoniae Infections in Infants and ChildrenView full resource at medicineandtechnology.com

  • View Related
  • Share

Most Recently Shared on September 27, 2010 at 11:02 am By:

DrJosephKim Joseph Kim, MD, MPH Doctor and Physician

Prevention of Streptococcus pneumoniae Infections in Infants and Children http://goo.gl/fb/ujGbB

2 years ago...

Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine

cdc.gov — “Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide VaccineView full resource at cdc.gov

  • View Related
  • Share

Most Recently Shared on December 10, 2010 at 2:52 pm By:

HealthTrendster HealthTrendster Health Executive

RECOMMENDATIONS AND REPORTS: Prevention of Pneumococcal Disease Among Infants and Children… http://goo.gl/fb/p6HR3

1 year ago...

FDA Greenlights Pneumonia Vaccine

medicalnewstoday.com — “The FDA has approved Prevnar 13, for use on people over 50. Prevnar 13 is a pneumococcal 13-valent conjugate vaccine, that can prevent pneumonia and disease caused by the bacterium, StreptococView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 2, 2012 at 6:05 pm By:

AsthmaInTheNews Asthma News Health News

MedicalNewsToday: FDA Greenlights Pneumonia Vaccine http://t.co/CVwo11L4 Full http://t.co/XexlS93r

5 months ago...

EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13

news-medical.net — “Pfizer Inc. announced today that the European Commission has approved the Company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine, for active immunization for the prevention of vaccine-type invasive disease caused by Streptococcus pneumoniae in adults aged 50 years and older.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 27, 2011 at 12:13 pm By:

Meningitis_News News-Medical.Net Health News

Meningitis News: EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13: Pfizer Inc. announced today t... http://t.co/Tf9d5WUY

7 months ago...

WHO grants prequalification to Prevenar 13, Pfizer's 13-valent pneumococcal conjugate vaccine for infants & young children - Biotechnology

pharmabiz.com — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeksView full resource at pharmabiz.com

  • View Related
  • Share

Most Recently Shared on August 24, 2010 at 11:13 am By:

Lung_Breathing Lungs and Breathing OW Health

WHO grants prequalification to Prevenar 13, Pfizer's 13-valent pneumococcal conjugate vaccine for infants & young ... http://bit.ly/an8GLZ

2 years ago...

Pediatrics Article | Pneumococcal Vaccines

mdlinx.com — “Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of AgeView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 6, 2010 at 11:41 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age: C... http://bit.ly/biGZoT #peds

2 years ago...

Study urged for pneumococcal vaccine in low-income countries

pediatricsupersite.com — “Data from parts of Africa suggest that the 7-valent pneumococcal conjugate vaccine is making a dent in pneumococcal disease, all-cause pneumonia anView full resource at pediatricsupersite.com

  • View Related
  • Share

Most Recently Shared on February 20, 2012 at 8:27 pm By:

PedSuperSite Pediatric SuperSite Health Site

Study urged for pneumococcal vaccine in low-income countries: http://t.co/V7tdfkDn

3 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390